Disease / condition

Thrombosis, Venous clinical trials

Free access to 10 studies·6+ countries·Updated daily2 recruiting
10
Total trials
6+
Countries
3+
Sponsors
2
Recruiting
By phase
Phase 35
N/A5
By status
Completed8
Not yet recruit...2
Top countries
Belgium,Canada,Czech,France,Germany,Hungary,Italy,Netherlands,Poland,Russian Federation,Slovenia1
Bulgaria,Czech,Estonia,France,Germany,Greece,Hungary,Israel,Italy,Latvia,Netherlands,Poland,Russian 1
France,Germany,Italy,Netherlands,Russian Federation,Spain1
Israel1
Italy1
Top sponsors
GlaxoSmithKline8
IRCCS San Raffaele1
Meir Medical Cente...1
Recent trials
Latest clinical trials for Thrombosis, Venous
NCT06349291Not yet recr...
Venous Thrombosis After Removal of Central Venous Catheter
Meir Medical CenterIsrael
NCT06288906Not yet recr...
Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems
IRCCS San RaffaeleItaly
NCT01691495Completed
ARIXTRA® Adherence in SVT Patients.
GlaxoSmithKline
NCT01444612Completed
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
GlaxoSmithKline
NCT01064362Completed
Hemorrhage Risk Prescribed Arixtra
GlaxoSmithKline
NCT00911157·Phase 3Completed
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
GlaxoSmithKlineJapan
NCT00843492·Phase 3Completed
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
GlaxoSmithKlineFrance,Germany,Italy,Netherlands,Russian Federation,Spain
NCT00443053·Phase 3Completed
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
GlaxoSmithKlineBulgaria,Czech,Estonia,France,Germany,Greece,Hungary,Israel,Italy,Latvia,Netherlands,Poland,Russian
NCT00320398·Phase 3Completed
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
GlaxoSmithKline
NCT00312013·Phase 3Completed
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
GlaxoSmithKlineBelgium,Canada,Czech,France,Germany,Hungary,Italy,Netherlands,Poland,Russian Federation,Slovenia
About this record

Access comprehensive clinical trial information for Thrombosis, Venous through Pure Global AI's free database. This collection includes 10 clinical trials across multiple phases including Phase 3, N/A. Currently, 2 trials are actively recruiting participants.

Research for Thrombosis, Venous is being conducted in Belgium,Canada,Czech,France,Germany,Hungary,Italy,Netherlands,Poland,Russian Federation,Slovenia, Bulgaria,Czech,Estonia,France,Germany,Greece,Hungary,Israel,Italy,Latvia,Netherlands,Poland,Russian , France,Germany,Italy,Netherlands,Russian Federation,Spain and 3+ other countries. Leading sponsors include GlaxoSmithKline and IRCCS San Raffaele. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 10 clinical trials studying Thrombosis, Venous, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 6+ countries.

Top research sponsors include GlaxoSmithKline, IRCCS San Raffaele, Meir Medical Center, among others.